Tech Company M&A Transactions
Envoy Therapeutics Acquisition
Operating out of Jupiter, Envoy Therapeutics was acquired by Takeda Pharmaceuticals. The transaction price was $140 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/7/2012
Transaction Type
M&A
Amount
$140,000,000
M&A Terms
Takeda America Holdings will acquire 100% of the equity in Envoy for total consideration of up to $140MM, which includes an up-front payment and progress-dependent, preclinical milestone payments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
555 Heritage Drive
Jupiter, FL 33458
USA
Jupiter, FL 33458
USA
Phone
Website
Email Address
Overview
Envoy's mission is to discover new drugs that will help millions of people. Our bacTRAP® technology creates an unprecedented view into the protein expression profiles of specific cell types within the body and is particularly powerful in the brain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Paul Greengard
Co-Founder
Nathaniel Heintz
Browse more venture capital transactions:
Prev: 11/6/2012: Cellular Dynamics International venture capital transaction
Next: 11/7/2012: ServiceMax venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs